Investors

Roche’s First Quarter Sales 2026 Presentation

Roche has published its First Quarter Sales for 2026 prior to the opening of the Swiss Stock Exchange on Thursday, 23rd April 2026.

Please click here to watch the replay
Presentation download
Presentation with appendix

A blue-gloved hand delicately holds a small pink container with a QR code. Nearby are green, blue, and yellow containers on a white surface, indicating a scientific setting.

Roche’s Virtual AAN Investor Event

Roche has hosted a virtual event on Wednesday, 22 April 2026

Please click here to watch the replay
Presentation download

A gloved hand in a lab coat holds a small, clear vial against a blurred background of lab equipment, conveying a scientific and clinical setting.

Roche Diagnostics Day 2026

Tuesday, 12 May 2026 at 12:00 BST - London

More details

Investors at a glance

+11%

Core earnings per share growth at Constant Exchange Rates in 2025 (Core EPS 19.46 CHF - diluted)

39 million

patients were treated with Roche medicines in 2025

31 billion

Roche Diagnostic tests were delivered to customers worldwide in 2025

Product Development Pipeline

Read the letter to shareholders

Our two divisions are focusing jointly on three disease areas that will account for almost 50% of the global disease burden by 2035: cancer, cardiovascular-metabolic diseases and neurological diseases.

Dr Thomas Schinecker

CEO Roche Group

Investor updates

View all updates

View ad-hoc announcements

Upcoming Investor events

View all events

Berenberg Diagnostics ConferenceInvestors

May 06, 2026 at 08:00 BST | London, UK

Add to calendar

Berenberg R&D Leaders: Back to the FutureInvestors

May 12, 2026 at 08:00 EDT | Boston, US

Add to calendar

Roche Diagnostics Day 2026Investors

May 12, 2026 at 12:00 BST | London UK

Add to calendar

Bank of America Securities 2026 Healthcare ConferenceInvestors

May 14, 2026 at 08:00 PDT | Las Vegas, US

Add to calendar

Deutsche Bank Access European Champions ConferenceInvestors

May 26, 2026 at 08:00 CEST | Frankfurt, DE

Add to calendar

Bernstein 20th Annual Strategic Decisions ConferenceInvestors

May 27, 2026 at 08:00 EDT | New York, US

Add to calendar

Roche’s Investor Event at ASCO 2026Investors

June 02, 2026 at 14:00 CDT | Chicago, US

Add to calendar

Jefferies Global Life Science ConferenceInvestors

June 03, 2026 at 08:00 EDT | New York, US

Add to calendar

BNP Paribas Exane 28th CEO ConferenceInvestors

June 04, 2026 at 08:00 CEST | Paris, FR

Add to calendar

Latest reports

Annual report 2025Investors

Smiling scientist in a lab coat and safety glasses holds a pipette in a modern laboratory. The setting conveys focus and innovation.

Half-year report 2025Investors

Finance Information Tool

Reporting

Download center

Share and Bond information

US investors

ESG Index

Investor relations team contacts

Do you need to get in touch with us? Reach out to our investor relations team with your enquiries.

View investor contact detail

Discover More

Roche Diagnostics news

Follow the most recent updates from our Diagnostics business

Genentech

Genentech has been delivering on the promise of biotechnology for over 35 years.

Sustainability at RocheAbout Roche

At Roche, sustainability means operating with a long-term mindset – ensuring more people can benefit from our science and innovation today without compromising the world they will live in tomorrow.

Positions, policies & downloadsAbout Roche

Download our policies, guidelines, positions and other documents.

Frequently asked questionsInvestors

We answer the Roche investors-related most frequently asked questions

PartneringInnovation

At Roche Partnering, we are passionate about science: yours and ours. Through partnerships, we hope that together we can build a better future with medicines that make a real difference to patients.